Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2010
In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's diseaseR Scott Bitner, William H Bunnelle, Michael W Decker, et al.
Expert Opinion on Drug Discovery|March 20, 2013
The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditionsMichael W Decker, Murali Gopalakrishnan, Michael D Meyer
Biochemical and Biophysical Research Communications|December 21, 2004
A novel potassium channel encoded by Ectocarpus siliculosus virusJun Chen, Steven C Cassar, Di Zhang, et al.
Molecular Vision|November 10, 2004
Tissue specific expression of alternative splice forms of human cyclic nucleotide gated channel subunit CNGA3Steven C Cassar, Jun Chen, Di Zhang, et al.
Journal of Neurochemistry|May 20, 2008
Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cellsMin Hu, Jeffrey F Waring, Murali Gopalakrishnan, et al.
Life Sciences|December 7, 2007
Characterization of human ASIC2a homomeric channels stably expressed in murine Ltk- cellsJohn Malysz, Victoria E Scott, Connie Faltynek, et al.
Neuropharmacology|November 4, 2010
In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's diseaseR Scott Bitner, Stella Markosyan, Arthur L Nikkel, et al.
Psychopharmacology|November 1, 2011
Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosisKathy L Kohlhaas, Robert S Bitner, Murali Gopalakrishnan, et al.
Biochemical Pharmacology|August 21, 2007
Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeysJerry J Buccafusco, Alvin V Terry, Michael W Decker, et al.
European Journal of Pharmacology|June 27, 2003
Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferationAshutosh S Parihar, Michael J Coghlan, Murali Gopalakrishnan, et al.
Pageof 10